However, inconsistent with the findings of a previous meta-analysis focusing on anti-PD-1 drugs (24), this meta-analysis found that the addition of ICIs did not significantly increase the incidence of pneumonitis or colitis. The gene discussed is PDCD1; the disease is pneumonitis.